Hemophilia Perspectives: An Update on Risk Stratification, Eradication, and Management of Hemophilia Patients with Inhibitors


This interactive educational activity is divided into 3 parts. Part A provides an update on the risks of inhibitor development. Part B focuses on the eradication and treatment of patients with inhibitors. In between parts A and B, we discuss a case about a patient with hemophilia A and a factor VIII inhibitor.